We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$151M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$48.3M
3
ITOS
iTeos Therapeutics
ITOS
+$21.3M
4
QNGY
Quanergy Systems, Inc.
QNGY
+$11.5M
5
FULC icon
Fulcrum Therapeutics
FULC
+$10.9M

Top Sells

Rank Stock Value
1
SMH icon
VanEck Semiconductor ETF
SMH
+$30.8M
2
DIS icon
Walt Disney
DIS
+$23.1M
3
NGHC
National General Holdings Corp
NGHC
+$20.7M
4
STLA icon
Stellantis
STLA
+$19.7M
5
SVOKU
Seven Oaks Acquisition Corp. Unit
SVOKU
+$16M

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
301
PUT
Citigroup
C
$227B
$136K 0.01%
+16,900
New +$1.13M
BLUE
302
DELISTED
bluebird bio
BLUE
$130K 0.01%
+332
New +$163K
VRTX icon
303
CALL
Vertex Pharmaceuticals
VRTX
$135B
$129K 0.01%
15,800
+8,300
+111% +$1.82M
GMBTW
304
DELISTED
Pivotal Holdings Corp Warrant
GMBTW
$129K 0.01%
+121,016
New +$139K
KSU
305
CALL
DELISTED
Kansas City Southern
KSU
$127K 0.01%
+13,200
New +$2.87M
EQIX icon
306
PUT
Equinix
EQIX
$102B
$126K 0.01%
3,500
– –
FFAI
307
PUT
Faraday Future Intelligent Electric
FFAI
$10.7M
– –
0
– –
BNZIW
308
DELISTED
Banzai International Warrant
BNZIW
$124K 0.01%
+163,798
New +$188K
NUVB.WS
309
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$124K 0.01%
+46,554
New +$135K
DCPH
310
PUT
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$124K 0.01%
30,000
+9,800
+49% +$456K
VFF icon
311
CALL
Village Farms International
VFF
$295M
$123K 0.01%
44,500
+2,000
+5% +$28.7K
HZON
312
DELISTED
Horizon Acquisition Corporation II
HZON
$122K 0.01%
+11,934
New +$127K
FE icon
313
CALL
FirstEnergy
FE
$27.2B
$113K 0.01%
+94,900
New +$3.1M
CNST
314
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$113K 0.01%
+4,813
New +$146K
TPGY.WS
315
DELISTED
TPG Pace Beneficial Finance Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TPGY.WS
$111K 0.01%
+14,875
New +$124K
CZR icon
316
PUT
Caesars Entertainment
CZR
$6.06B
$110K 0.01%
84,000
-138,500
-62% -$11.6M
IPOD
317
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$110K 0.01%
+10,000
New +$142K
CHRS icon
318
Coherus Oncology
CHRS
$187M
$109K 0.01%
+7,479
New +$127K
SWCH
319
PUT
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$108K 0.01%
139,600
+35,300
+34% +$588K
EQIX icon
320
CALL
Equinix
EQIX
$102B
$104K 0.01%
3,500
– –
HERAU
321
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
$102K 0.01%
+10,242
New +$103K
FOLD
322
CALL
DELISTED
Amicus Therapeutics
FOLD
$101K 0.01%
160,600
+65,000
+68% +$1.01M
VYGG
323
DELISTED
Vy Global Growth
VYGG
$101K 0.01%
10,000
-81,961
-89% -$906K
FOLD
324
DELISTED
Amicus Therapeutics
FOLD
$99K 0.01%
+10,000
New +$155K
FOLD
325
PUT
DELISTED
Amicus Therapeutics
FOLD
$99K 0.01%
+74,900
New +$1.16M
11 12
13
14 15

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.